EP0989860A4 - Methods and compositions for inactivating infectious agents using lactoferrin and related molecules - Google Patents
Methods and compositions for inactivating infectious agents using lactoferrin and related moleculesInfo
- Publication number
- EP0989860A4 EP0989860A4 EP99917408A EP99917408A EP0989860A4 EP 0989860 A4 EP0989860 A4 EP 0989860A4 EP 99917408 A EP99917408 A EP 99917408A EP 99917408 A EP99917408 A EP 99917408A EP 0989860 A4 EP0989860 A4 EP 0989860A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- lactoferrin
- compositions
- methods
- infectious agents
- related molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16061—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8156498P | 1998-04-13 | 1998-04-13 | |
US81564P | 1998-04-13 | ||
PCT/US1999/007931 WO1999052545A1 (en) | 1998-04-13 | 1999-04-12 | Methods and compositions for inactivating infectious agents using lactoferrin and related molecules |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0989860A1 EP0989860A1 (en) | 2000-04-05 |
EP0989860A4 true EP0989860A4 (en) | 2000-07-19 |
Family
ID=22164962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99917408A Withdrawn EP0989860A4 (en) | 1998-04-13 | 1999-04-12 | Methods and compositions for inactivating infectious agents using lactoferrin and related molecules |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0989860A4 (en) |
JP (1) | JP2002508009A (en) |
AU (1) | AU3554099A (en) |
CA (1) | CA2294018A1 (en) |
WO (1) | WO1999052545A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2527904A1 (en) * | 2003-06-06 | 2005-05-26 | Agennix Incorporated | Lactoferrin as an adjuvant in cancer vaccines |
GB0409748D0 (en) | 2004-04-30 | 2004-06-09 | Chiron Srl | Lactoferrin cleavage |
ITRM20080163A1 (en) * | 2008-03-26 | 2009-09-27 | Maurizio Acri | USE OF LATTOFERRINA FOR THE PREVENTION OF NEONATAL SEPSIS IN PREMATURED NEWBORNS |
CN107586334B (en) * | 2017-08-29 | 2020-06-23 | 杭州医学院 | Preparation method of serum for treating haemophilus influenzae infection and application of serum |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03220130A (en) * | 1990-01-25 | 1991-09-27 | Snow Brand Milk Prod Co Ltd | Agent inhibitory against implantation of pathogenic microorganism and food and drink or the like containing the same inhibitory agent |
US5304633A (en) * | 1990-09-07 | 1994-04-19 | Morinaga Milk Industry Co., Ltd. | Fragments of lactoferrin having potent antimicrobial activity |
WO1997005884A1 (en) * | 1995-08-07 | 1997-02-20 | New England Medical Center Hospitals, Inc. | Infant formula and infant formula additives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3100005B2 (en) * | 1992-07-28 | 2000-10-16 | 雪印乳業株式会社 | Human immunodeficiency virus infection / growth inhibitor |
JP3312946B2 (en) * | 1993-03-04 | 2002-08-12 | 雪印乳業株式会社 | Virus infection / growth inhibitor |
NZ330484A (en) * | 1994-02-16 | 1999-11-29 | Pharming Bv | Isolation of lactoferrin especially recombinant lactoferrin from milk |
US5834424A (en) * | 1995-07-12 | 1998-11-10 | Gambit International Limited | Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus |
-
1999
- 1999-04-12 JP JP55193499A patent/JP2002508009A/en active Pending
- 1999-04-12 EP EP99917408A patent/EP0989860A4/en not_active Withdrawn
- 1999-04-12 WO PCT/US1999/007931 patent/WO1999052545A1/en not_active Application Discontinuation
- 1999-04-12 AU AU35540/99A patent/AU3554099A/en not_active Abandoned
- 1999-04-12 CA CA002294018A patent/CA2294018A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03220130A (en) * | 1990-01-25 | 1991-09-27 | Snow Brand Milk Prod Co Ltd | Agent inhibitory against implantation of pathogenic microorganism and food and drink or the like containing the same inhibitory agent |
US5304633A (en) * | 1990-09-07 | 1994-04-19 | Morinaga Milk Industry Co., Ltd. | Fragments of lactoferrin having potent antimicrobial activity |
WO1997005884A1 (en) * | 1995-08-07 | 1997-02-20 | New England Medical Center Hospitals, Inc. | Infant formula and infant formula additives |
Non-Patent Citations (5)
Title |
---|
DATABASE WPI Section Ch Week 199145, Derwent World Patents Index; Class B04, AN 1991-329196, XP002138451 * |
LEGRAND, D., ET AL.: "Evidence for interactions between the 30kDa N- and 50kDa C-terminal tryptic fragments of human lactotransferrin", BIOCHEM. J., vol. 236, 1986, pages 839 - 844, XP002921478 * |
QUI, J., ET AL.: "Human milk lactoferrin extracts the IgA protease precursor from the outer membrane of growing Heamophilus influenzae cells", ABSTRACTS OF THE INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY AND MEETING INFO OF THE 35TH INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY SAN FRANCISCO, SEPT- 17-20, vol. 35, no. 0, 1995, california, usa, pages 160, XP000886820 * |
See also references of WO9952545A1 * |
WITTLER, M., ET AL.: "Neutralization of streptococcus sanguis IgA-1 protease by lactoferrin and transferrin", JOURNAL OF DENTAL RESEARCH AND MEETING INFO.: JOINT MEETING OF THE INTERNATIONAL ASSOCIATION FOR DENTAL RESEARCH, THE AMERICAN ASSOCIATION OF DENTAL RESEARCH AND THE CANADIAN ASSOCIATION OF DENTAL RESEARCH CHICAGO, 10-14, 1993, vol. 72, 1993, illinois, usa, pages 327, XP000886807 * |
Also Published As
Publication number | Publication date |
---|---|
JP2002508009A (en) | 2002-03-12 |
AU3554099A (en) | 1999-11-01 |
EP0989860A1 (en) | 2000-04-05 |
CA2294018A1 (en) | 1999-10-21 |
WO1999052545A1 (en) | 1999-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9901053A3 (en) | Disinfecting compositions and processes for disinfecting surfaces | |
IL125237A0 (en) | Disinfecting compositions and processes for disinfecting surfaces | |
IL133187A0 (en) | Disinfecting compositions and processes for disinfecting surfaces | |
HK1023371A1 (en) | Compositions and methods for treating viral infections | |
EP1052988A4 (en) | Methods and compositions for inactivating viruses | |
BG105437A (en) | Rheoogy modified compositions and processes thereof | |
EP1056456A4 (en) | R-lansoprazole compositions and methods | |
DE69918842D1 (en) | DISINFECTION COMPOSITIONS AND METHODS | |
HUP9901063A3 (en) | Disinfecting compositions and processes for disinfecting surfaces | |
EP1056457A4 (en) | S-lansoprazole compositions and methods | |
EP1083915A4 (en) | Compositions and methods for enhancing protein anabolism and detoxification | |
EP0980202A4 (en) | Methods for viral inactivation and compositions for use in same | |
PL332616A1 (en) | Hydoxymethylhexanones as odorising and savourising agents | |
EP1073333A4 (en) | S-rabeprazole compositions and methods | |
EP0989860A4 (en) | Methods and compositions for inactivating infectious agents using lactoferrin and related molecules | |
EP1088067A4 (en) | Methods and compositions for modulating spermatogenesis | |
EP1135476A4 (en) | Biological compositions, components thereof and uses therefor | |
AU2003204545A1 (en) | Methods and compositions for inactivating viruses | |
HUP0100613A3 (en) | Methods and compositions for stabilizing acetylcholine compositions | |
GB9828356D0 (en) | Protein and compositions containing it | |
GB9828352D0 (en) | Protein and compositions containing it | |
GB9828349D0 (en) | Protein and compositions containing it | |
GB9828345D0 (en) | Protein and compositions containing it | |
GB9901233D0 (en) | Protein and compositions containing it | |
GB9922596D0 (en) | Protein and compositions containing it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK FR GB IE LI LU NL SE |
|
17P | Request for examination filed |
Effective date: 20000405 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20000606 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK FR GB IE LI LU NL SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 38/40 A, 7A 61K 39/02 B, 7A 61K 39/12 B, 7A 61K 39/145 B, 7C 07K 14/79 B, 7A 61P 31/04 B |
|
17Q | First examination report despatched |
Effective date: 20030929 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050315 |